US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Gastrointestinal Market Research Reports & Industry Analysis

RSS Feeds

Gastrointestinal Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Germany Gastro-Esophageal Reflux Disease Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... forecast in Germany. The research includes Germany gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux disease drugs market share, gastro-esophageal reflux disease drugs sales estimates, ...  |  read more...
USD 990
France Gastro-Esophageal Reflux Disease Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... forecast in France. The research includes France gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux disease drugs market share, gastro-esophageal reflux disease drugs sales estimates, ...  |  read more...
USD 990
Japan Gastro-Esophageal Reflux Disease Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... forecast in Japan. The research includes Japan gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux disease drugs market share, gastro-esophageal reflux disease drugs sales estimates, ...  |  read more...
USD 990
Plecanatide (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
Ulcerative Colitis Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... partnering deals Top ulcerative colitis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Ulcerative Colitis Partnering 2009-2014 provides understanding and access to the ulcerative colitis partnering deals ...  |  read more...
USD 1,495
Gastric Ulcers - Pipeline Review, H2 2015
9/9/2015 | published by: Global Markets Direct
... therapeutic development for Gastric Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Gastric Cancer Partnering 2010-2015
3/1/2015 | published by: Current Partnering
... partnering deals Top gastric cancer deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Gastric Cancer Partnering 2010-2015 provides understanding and access to the gastric cancer partnering deals ...  |  read more...
USD 1,495
The 2016 Report on Digestion Aids: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting ...  |  read more...
USD 995
The 2016 Report on Dyspepsia Medications: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting ...  |  read more...
USD 995
The 2016 Report on Herbal Digestion Aids: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by ...  |  read more...
USD 995
The 2016-2021 World Outlook for Peptic Ulcer Testing
4/6/2015 | published by: Icon Group International, Inc.
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader ...  |  read more...
USD 995
The 2016-2021 World Outlook for Pharmaceutical Preparations Acting on the Digestive or Genito-Urinary Systems
4/6/2015 | published by: Icon Group International, Inc.
... 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...  |  read more...
USD 995
The 2016-2021 World Outlook for Pharmaceutical Preparations for Human Use Acting on the Digestive or the Genito-Urinary Systems
4/6/2015 | published by: Icon Group International, Inc.
... digestive or the genito-urinary systems across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ...  |  read more...
USD 995
Global Inflammatory Bowel Disease Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... Top inflammatory bowel disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Inflammatory Bowel Disease Partnering 2010-2015 provides understanding and access to the inflammatory bowel disease partnering ...  |  read more...
USD 1,495
Global Gastrointestinal Symptoms Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Gastrointestinal Symptoms Partnering 2010-2015 provides understanding and access to the gastrointestinal symptoms partnering deals and agreements entered into by ...  |  read more...
USD 1,495
The 2016 Report on Laxatives and Stool Softeners: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so ...  |  read more...
USD 995
Ileus (Intestinal Obstruction) Global Clinical Trials Review, H1, 2015
4/30/2015 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Ileus (Intestinal Obstruction) . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ...  |  read more...
USD 2,500
Diarrhea Global Clinical Trials Review, H1, 2015
5/29/2015 | published by: GlobalData
... to the clinical trials on Diarrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015
6/30/2015 | published by: GlobalData
... Reflux Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Reflux Esophagitis (Gastroesophageal Reflux Disease) . Report includes an overview of trial numbers and their average enrollment in ...  |  read more...
USD 2,500
Inflammatory Bowel Disease - Pipeline Review, H1 2015
6/30/2015 | published by: Global Markets Direct
... information on the therapeutic development for Inflammatory Bowel Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Tenapanor (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies indicated for ...  |  read more...
USD 3,495
PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies ...  |  read more...
USD 4,995
PharmaPoint: Irritable Bowel Syndrome - Japan Drug Forecast and Market Analysis to 2023
12/31/2014 | published by: GlobalData
... not a life-threatening disorder, it has a considerable effect on patients’ quality of life (QOL). In terms of volume, the IBS market is a large, albeit naïve, one, with only a small number of pharmacotherapies ...  |  read more...
USD 4,995
Gastric Ulcers - Pipeline Review, H1 2015
2/18/2015 | published by: Global Markets Direct
... therapeutic development for Gastric Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Acid Indigestion / Heartburn/ Pyrosis-API Insights, 2015
4/21/2015 | published by: DelveInsight
... the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Acid Indigestion / Heartburn/ Pyrosis. The ...  |  read more...
USD 1,250
6  7  8  9    11    13  14  15